Name: UMIN ID:
Unique ID issued by UMIN | UMIN000031281 |
---|---|
Receipt number | R000035704 |
Scientific Title | Open-label clinical study for safety and preliminary efficacy of HiDCV-OS1 Hybrid cell (dendritic and tumor fusion cells) and subsequent subcutaneous administration of GEN0101 in patients with recalcitrant residual or relapsed ovarian cancer after strict chemotherapy. |
Date of disclosure of the study information | 2018/02/13 |
Last modified on | 2023/08/07 14:48:43 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/02/13 17:50:46 | ||
2 | Update | 2018/02/14 18:41:34 | Key inclusion criteria |
|
3 | Update | 2018/05/30 15:20:51 | Recruitment status |
|
4 | Update | 2021/02/17 10:17:05 | Recruitment status Date of IRB Last follow-up date |
|
5 | Update | 2023/08/07 13:30:53 | Recruitment status |
|
6 | Update | 2023/08/07 13:43:31 | Publication of results Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Plan to share IPD Plan to share IPD IPD sharing Plan description IPD sharing Plan description |
|
7 | Update | 2023/08/07 14:34:28 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Organization Address Address Tel |
|
8 | Update | 2023/08/07 14:48:43 | Baseline Characteristics |